TABLE 1.
Common renal function and lipid indicators of the study subjects.
| Group | HC (n = 45) | BKT (n = 40) | RCC (n = 46) | χ2/F, P |
|---|---|---|---|---|
| UA (μmol/L) | 332.0 (269.3, 371.7) | 282.4 (229.0, 350.8) | 333.3 (236.4, 417.1) | 4.354a, 0.113 |
| C1q (mg/L) | 207.0 (175.5, 235.5) | 193.5 (168.4, 229.0) | 191.5 (166.6, 221.8) | 1.366a, 0.505 |
| NGAL (μg/L) | 95.0 (78.5, 113.0) | 124.0 (85.3, 180.0) * | 130.1 (93.0, 164.8) * | 13.799a, 0.001 |
| Urea (mmol/L) | 5.10 (4.13, 5.64) | 5.37 (4.07, 6.60) | 5.43 (4.46, 6.59) | 4.215a, 0.122 |
| Cr (μmol/L) | 66.0 (53.4, 78.0) | 65.6 (54.2, 87.6) | 80.1 (61.7, 105.7) * | 11.775a, 0.003 |
| CysC (mg/L) | 0.91 (0.79, 1.00) | 0.92 (0.76, 1.18) | 1.07 (0.90, 1.26) * | 13.391a, 0.001 |
| eGFR (ml/min/1.73m2) | 88.59 ± 12.29 | 85.75 ± 24.14 | 73.09 ± 20.85 * | 8.057b, 0.001 |
| TC (mmol/L) | 4.58 ± 0.59 | 4.89 ± 1.11 | 5.17 ± 1.37 * | 3.297b, 0.040 |
| TG (mmol/L) | 0.98 (0.87, 1.19) | 1.29 (0.99, 2.37) * | 1.39 (0.98, 1.97) * | 13.261a, 0.001 |
| HDL-C (mmol/L) | 1.38 (1.14, 1.55) | 1.31 (1.17, 1.64) | 1.22 (1.05, 1.45) | 2.717a, 0.257 |
| LDL-C (mmol/L) | 2.60 (2.27, 2.96) | 3.13 (2.26, 3.56) * | 2.99 (2.32, 4.31) * | 9.355a, 0.009 |
| Apo-A1 (g/L) | 1.55 ± 0.21 | 1.53 ± 0.31 | 1.48 ± 0.27 | 0.834b, 0.437 |
| Apo-B (g/L) | 0.81 ± 0.14 | 0.93 ± 0.24* | 1.00 ± 0.30* | 7.263b, 0.001 |
Note: n, case; a is the χ2 value; b is the value of F; HC, healthy control; BKT, benign kidney tumor; RCC, renal cell carcinoma; Cr, creatinine; UA, uric acid; CysC, cystatin C; C1q, complement C1q; NGAL, neutrophil gelatinase-associated lipocalin; eGFR, estimated glomerular filtration rate; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; Apo-A1, apolipoprotein A1; Apo-B, apolipoprotein B. Compared with HC, group, *p < 0.05. Compared with BKT, group, p < 0.05.